Clinical Efficacy and Safety of Platelets in Additive Solution Treated With Two Commercial Pathogen Reduction Technologies

被引:0
|
作者
Rebulla, P. [1 ]
Vaglio, S. [2 ]
Aprili, G. [6 ]
Beccaria, F.
Coluzzi, S. [3 ]
Girelli, G. [3 ]
Graf, M. [7 ]
Isernia, P. [8 ]
Marconi, M. [1 ]
Olivero, B. [1 ]
Rinaldi, M. [6 ]
Salvaneschi, L. [7 ]
Scarpato, N. [7 ]
Strada, P.
McCullough, J. [4 ]
Heddle, N. M. [5 ]
Grazzini, G. [2 ]
机构
[1] Politecn Milan, I-20133 Milan, Italy
[2] CNS, Rome, Italy
[3] Ctr Transfus Rome, Rome, Italy
[4] Univ Minnesota, Minneapolis, MN USA
[5] McMaster Univ, Hamilton, ON, Canada
[6] Ctr Transfus Verona, Verona, Italy
[7] Ctr Transfus Naples, Naples, Italy
[8] Ctr Trasfus Pavia, Pavia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2-030A
引用
收藏
页码:3A / 4A
页数:2
相关论文
共 50 条
  • [1] Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies
    Rebulla, Paolo
    Vaglio, Stefania
    Beccaria, Francesco
    Bonfichi, Maurizio
    Carella, Angelo
    Chiurazzi, Federico
    Coluzzi, Serelina
    Cortelezzi, Agostino
    Gandini, Giorgio
    Girelli, Gabriella
    Graf, Maria
    Isernia, Paola
    Marano, Giuseppe
    Marconi, Maurizio
    Montemezzi, Rachele
    Olivero, Barbara
    Rinaldi, Marianna
    Salvaneschi, Laura
    Scarpato, Nicola
    Strada, Paolo
    Milani, Silvano
    Grazzini, Giuliano
    [J]. TRANSFUSION, 2017, 57 (05) : 1171 - 1183
  • [2] Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology
    Ostrowski, Sisse R.
    Bochsen, Louise
    Windelov, Nis A.
    Salado-Jimena, Jose A.
    Reynaerts, Inge
    Goodrich, Raymond P.
    Johansson, Par I.
    [J]. TRANSFUSION, 2011, 51 (02) : 344 - 356
  • [3] In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology
    Ostrowski, Sisse R.
    Bochsen, Louise
    Salado-Jimena, Jose A.
    Ullum, Henrik
    Reynaerts, Inge
    Goodrich, Raymond P.
    Johansson, Par I.
    [J]. TRANSFUSION, 2010, 50 (10) : 2210 - 2219
  • [4] Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)
    Marschner, S.
    Cardigan, R.
    Cookson, P.
    de Korte, Dirk
    Dumont, Larry J.
    Einarson, M.
    Herschel, L.
    Janetzko, K.
    Vassallo, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 148A - 148A
  • [5] Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 97A - 98A
  • [6] ACETATE CONSUMPTION IN PLATELETS TREATED WITH DIFFERENT PATHOGEN REDUCTION TECHNOLOGIES
    Marschner, S.
    Hovenga, N.
    Gathof, B.
    Picker, S.
    de Korte, D.
    Goodrich, R.
    [J]. VOX SANGUINIS, 2010, 99 : 247 - 247
  • [7] The platelets' perspective to pathogen reduction technologies
    Osman, Abdimajid
    Hitzler, Walter E.
    Provost, Patrick
    [J]. PLATELETS, 2018, 29 (02) : 140 - 147
  • [8] In Vitro Cell Quality Tests of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 93A - 94A
  • [9] Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction
    AuBuchon, JP
    Herschel, L
    Roger, J
    Taylor, H
    Whitley, P
    Li, JZ
    Edrich, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (08) : 1335 - 1341
  • [10] Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction
    Aubuchon, JP
    Herschel, L
    Roger, J
    Taylor, H
    Whitley, P
    Li, J
    Edrich, R
    Goodrich, RP
    [J]. TRANSFUSION, 2004, 44 (09) : 16A - 17A